OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Omicron BQ.1.1 and XBB.1 unprecedentedly escape broadly neutralizing antibodies elicited by prototype vaccination
Bin Ju, Qing Fan, Congcong Liu, et al.
Cell Reports (2023) Vol. 42, Iss. 6, pp. 112532-112532
Open Access | Times Cited: 16

Showing 16 citing articles:

Spatiotemporal dynamics and epidemiological impact of SARS-CoV-2 XBB lineage dissemination in Brazil in 2023
Ighor Arantes, Marcelo Ferreira da Costa Gomes, Kimihito Ito, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 5

Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineering
Yunji Liao, Hang Ma, Zhenyu Wang, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 6
Open Access

NIEAs elicited by wild-type SARS-CoV-2 primary infection fail to enhance the infectivity of Omicron variants
Qi Gui, Haiyan Wang, Congcong Liu, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access

Rapid clonal expansion and somatic hypermutation contribute to the fate of SARS-CoV-2 broadly neutralizing antibodies
Miao Wang, Congcong Liu, Qing Fan, et al.
The Journal of Immunology (2025)
Closed Access

Serial Llama Immunization with Various SARS-CoV-2 RBD Variants Induces Broad Spectrum Virus-Neutralizing Nanobodies
Pavel P. Solodkov, Alexander M. Najakshin, Nikolai A. Chikaev, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 129-129
Open Access | Times Cited: 3

Engineered Multivalent Nanobodies Efficiently Neutralize SARS-CoV-2 Omicron Subvariants BA.1, BA.4/5, XBB.1 and BQ.1.1
Jiali Wang, Bingjie Shi, Hanyi Chen, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 417-417
Open Access | Times Cited: 1

Ancestral SARS-CoV-2 immune imprinting persists on RBD but not NTD after sequential Omicron infections
Zuowei Wang, Ling Li, Ruiping Du, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Lessons from COVID‐19: Aspects of prevention, therapeutics, and diagnostics against SARS‐CoV‐2 with special focus on JN.1 and XBB sublineages
Puja Jaishwal, Upagya Gyaneshwari, Kisalay Jha, et al.
MedComm – Future Medicine (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 1

Ancestral SARS-CoV-2 immune imprinting persists on RBD but not NTD after sequential Omicron infections
Zuowei Wang, Ling Li, Ruiping Du, et al.
iScience (2024) Vol. 28, Iss. 1, pp. 111557-111557
Open Access | Times Cited: 1

Molecular Evolutionary Analyses of the Spike Protein Gene and Spike Protein in the SARS-CoV-2 Omicron Subvariants
Norika Nagasawa, Ryusuke Kimura, Mao Akagawa, et al.
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2336-2336
Open Access | Times Cited: 2

Spatiotemporal dynamics and epidemiological impact of SARS-CoV-2 XBB lineages dissemination in Brazil in 2023
Ighor Arantes, Marcelo Ferreira da Costa Gomes, Kimihito Ito, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Page 1

Scroll to top